Technology and Next Generation Oncology Trials
Embark on a new era of oncology trials with TD2, where advanced technology reshapes patient recruitment, engagement, and data analysis. Leveraging artificial intelligence and natural language tools, our strategies employ a combination of push and pull approaches to identify the right patients. From e-consent through telehealth services to automatic dispensing devices and wearables, our innovative solutions ensure patient engagement, compliance, and data collection beyond traditional trial sites. Explore the potential of disease-specific EMR systems and eClinical solutions for real-time treatment plans, data integration, and customized visualization, facilitating the development of drugs that truly benefit patients in early phase oncology trials.
